Veracyte, Inc. Insider Transactions
Veracyte, Inc. Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
EASTHAM KARIN
Director |
Sell | 5,309 @ $40.12 | $213,010 | 23,188 | 01/02/2025 | 01/06/2025 | |
EASTHAM KARIN
Director |
Sell | 4,691 @ $40.50 | $189,996 | 18,497 | 01/02/2025 | 01/06/2025 | |
Stapley Marc
CEO |
Sell | 5,190 @ $43.37 | $225,080 | 307,745 | 12/13/2024 | 12/17/2024 | |
Stapley Marc
CEO |
Sell | 400 @ $44.14 | $17,657 | 307,345 | 12/13/2024 | 12/17/2024 | |
Febbo Phillip G.
Chief Scientific & Med Officer |
Sell | 3,934 @ $44.09 | $173,447 | 82,414 | 12/04/2024 | 12/06/2024 | |
McGuire Annie
SVP, General Counsel |
Sell | 18,699 @ $44.02 | $823,179 | 72,869 | 12/04/2024 | 12/06/2024 | |
Wygant Jonathan
VP, CAO |
Sell | 956 @ $43.36 | $41,452 | 40,270 | 12/03/2024 | 12/04/2024 | |
Chambers Rebecca
CFO |
Sell | 7,000 @ $43.23 | $302,622 | 114,037 | 12/03/2024 | 12/04/2024 | |
Leite John
Chief Commercial Officer-CLIA |
Sell | 1,050 @ $43.25 | $45,408 | 73,810 | 12/03/2024 | 12/04/2024 | |
Wygant Jonathan
VP, CAO |
Sell | 5,032 @ $42.89 | $215,834 | 42,313 | 11/27/2024 | 11/29/2024 | |
EASTHAM KARIN
Director |
Sell | 1,600 @ $36.77 | $58,826 | 31,628 | 11/19/2024 | 11/21/2024 | |
EASTHAM KARIN
Director |
Sell | 3,006 @ $37.77 | $113,538 | 28,622 | 11/19/2024 | 11/21/2024 | |
EASTHAM KARIN
Director |
Sell | 10,125 @ $38.76 | $392,405 | 18,497 | 11/19/2024 | 11/21/2024 | |
Chambers Rebecca
CFO |
Sell | 15,275 @ $38.34 | $585,663 | 124,501 | 11/12/2024 | 11/14/2024 | |
EPSTEIN ROBERT S
Director |
Sell | 15,000 @ $38.32 | $574,830 | 44,598 | 11/12/2024 | 11/14/2024 | |
JONES EVAN/ FA
Director |
Sell | 5,173 @ $35.23 | $182,263 | 0 | 09/19/2024 | 09/23/2024 | |
Leite John
Chief Commercial Officer-CLIA |
Sell | 5,479 @ $29.78 | $163,159 | 76,174 | 09/04/2024 | 09/06/2024 | |
JONES EVAN/ FA
Director |
Sell | 688 @ $32.77 | $22,544 | 34,343 | 08/13/2024 | 08/14/2024 | |
JONES EVAN/ FA
Director |
Sell | 16,838 @ $32.36 | $544,851 | 35,031 | 08/13/2024 | 08/14/2024 | |
JONES EVAN/ FA
Director |
Sell | 2,931 @ $31.19 | $91,406 | 51,869 | 08/13/2024 | 08/14/2024 |
Veracyte, Inc. FAQ's
The list of insiders at Veracyte, Inc. includes JONES EVAN/ FA, EASTHAM KARIN, Bhanji Muna, Leite John, Holstein Jens, Chambers Rebecca, EPSTEIN ROBERT S, Wygant Jonathan, McGuire Annie, Febbo Phillip G., Stapley Marc.
Insiders have sold a total of 213,314 Veracyte, Inc. shares in the last 12 months for a total of 7.28 M sold.
The following insiders have sold Veracyte, Inc. shares in the last 12 months: JONES EVAN/ FA ($2.33 M), EASTHAM KARIN ($1.50 M), Bhanji Muna ($110,953), Leite John ($240,492), Holstein Jens ($137,500), Chambers Rebecca ($888,285), EPSTEIN ROBERT S ($574,830), Wygant Jonathan ($257,286), McGuire Annie ($823,179), Febbo Phillip G. ($173,447), Stapley Marc ($242,737),